Mammalian liver has evolved as a key organ in the maintenance of systemic glucose and lipid homeostasis. Hepatic glucose secretion is essential for maintaining nearly constant glucose levels under various nutritional conditions. The transcriptional coactivator PGC-1alpha has been shown to activate the entire program of gluconeogenesis; elevated PGC-1alpha activities may be a major contributor to hyperglycemia in diabetes. In addition, PGC-1alpha induces the expression of genes involved in a-oxidation of fatty acids and ketogenesis, suggesting that PGC-1alpha may underlie the broad program of metabolic adaptation to fasting in the liver. Recently we have shown that PGC-1beta, a coactivator closely related to PGC-1alpha, drastically elevates plasma triglyceride levels when expressed in the rat liver. These findings raise the possibility that PGC-1beta may be a key factor in the control of lipid homeostasis and play an important role in the pathogenesis of dyslipidemia in obesity and diabetes. This proposal describes several experiments to critically assess the role of PGC-1a in hepatic gluconeogenesis in response to fasting and in diabetes. These studies will also provide insight in to the control of multiple metabolic programs in the liver that enable an organism to survive in the face of nutritional deprivation. Using mouse genetic approaches, the function of PGC-1beta in the control of lipid metabolism will be examined, and importantly, its involvement in the pathogenesis of dyslipidemia will be investigated. The mechanistic basis of PGC-1beta action will be explored. Finally, a crucial aspect of the metabolic regulation by the PGC-1 family coactivators is to establish how their activities are modulated. The proposed studies will not only enhance our knowledge about the control of cellular energy metabolism, but also reveal novel therapeutic targets for the treatment of diabetes and its associated complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01DK065584-05
Application #
7320640
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
2004-02-15
Project End
2008-06-30
Budget Start
2007-12-01
Budget End
2008-06-30
Support Year
5
Fiscal Year
2008
Total Cost
$95,084
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Li, Siming; Liu, Chang; Li, Na et al. (2008) Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab 8:105-17
Lin, Jiandie D; Liu, Chang; Li, Siming (2008) Integration of energy metabolism and the mammalian clock. Cell Cycle 7:453-7
Uldry, Marc; Yang, Wenli; St-Pierre, Julie et al. (2006) Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab 3:333-41
Lin, Jiandie; Handschin, Christoph; Spiegelman, Bruce M (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361-70
Lin, Jiandie; Yang, Ruojing; Tarr, Paul T et al. (2005) Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 120:261-73
Handschin, Christoph; Lin, Jiandie; Rhee, James et al. (2005) Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 122:505-15
Arany, Zoltan; He, Huamei; Lin, Jiandie et al. (2005) Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1:259-71
Lin, Jiandie; Wu, Pei-Hsuan; Tarr, Paul T et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119:121-35